| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 740.110 | 766.244 | 858.903 | 764.742 | 759.837 | 728.741 | 736.258 | 307.923 | 29.995 | 30.002 |
| Total Income - EUR | 743.671 | 775.787 | 859.663 | 766.074 | 761.879 | 730.924 | 738.449 | 920.409 | 30.002 | 35.218 |
| Total Expenses - EUR | 653.816 | 674.228 | 744.677 | 680.529 | 699.068 | 665.142 | 659.359 | 284.855 | 23.761 | 27.943 |
| Gross Profit/Loss - EUR | 89.854 | 101.560 | 114.985 | 85.544 | 62.811 | 65.782 | 79.090 | 635.554 | 6.241 | 7.274 |
| Net Profit/Loss - EUR | 77.348 | 87.289 | 98.299 | 77.758 | 56.279 | 59.946 | 73.962 | 628.277 | 6.016 | 6.980 |
| Employees | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 3 | 1 | 1 |
Check the financial reports for the company - Farmacia Iris Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19.518 | 42.604 | 32.084 | 22.858 | 14.507 | 5.727 | 4.368 | 3.269 | 2.243 | 2.230 |
| Current Assets | 357.150 | 386.552 | 441.787 | 446.729 | 512.279 | 533.667 | 543.393 | 669.385 | 70.128 | 76.437 |
| Inventories | 30.227 | 32.498 | 37.336 | 31.763 | 39.296 | 42.808 | 29.678 | 0 | 0 | 0 |
| Receivables | 24.996 | 11.759 | 37.869 | 46.898 | 27.752 | 18.835 | 20.954 | 612.057 | 3.819 | 3.848 |
| Cash | 301.928 | 342.295 | 366.581 | 368.068 | 445.232 | 472.025 | 492.761 | 57.329 | 66.310 | 72.589 |
| Shareholders Funds | 242.110 | 264.002 | 230.486 | 304.014 | 271.799 | 326.592 | 393.311 | 671.234 | 68.725 | 49.568 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 134.558 | 165.153 | 243.385 | 165.574 | 254.987 | 212.803 | 154.449 | 1.420 | 3.646 | 29.099 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Farmacia Iris Srl